Myo19 - myosin XIX Gene

Also Known as Myohd1; 1110055A02Rik

Species: Mus musculus

Gene Type: protein coding
Gene ID: 66196

Summary

Enables ATP hydrolysis activity; Myosin light chain binding activity; and plus-end directed microfilament motor activity. Predicted to be involved in several processes, including actin filament organization; regulation of mitochondrial fission; and vesicle transport along actin filament. Predicted to act upstream of or within mitochondrion migration along actin filament. Predicted to be located in cytosol and mitochondrial outer membrane. Predicted to be part of Myosin complex. Predicted to be active in actin cytoskeleton; cytoplasm; and vesicle. Is expressed in adenohypophysis; alimentary system; skeleton; vibrissa; and vomeronasal organ. Orthologous to human MYO19 (Myosin XIX). [provided by Alliance of Genome Resources, Apr 2022]

Myo19 Products (2)

mRNA Protein Name
NM_001362893.1 NP_001349822.1 unconventional myosin-XIX isoform 2
NM_025414.4 NP_079690.2 unconventional myosin-XIX isoform 1

Gene Ontology

  • Molecular Function
  • Biological Process
Molecular Function GO Annotation Evidence References Source
enables ATP hydrolysis activity IDA
IDA: Inferred from direct assay
24825904 MGI
enables myosin light chain binding IPI
IPI: Inferred from physical interaction
24825904 MGI
enables plus-end directed microfilament motor activity IDA
IDA: Inferred from direct assay
24825904 MGI
Biological Process GO Annotation Evidence References Source
acts upstream of or within mitocytosis IDA
IDA: Inferred from direct assay
34048705 MGI
acts upstream of or within mitocytosis IMP
IMP: Inferred from mutant phenotype
34048705 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

unconventional myosin-XIX

  • myosin head domain containing 1

  • myosin head domain-containing protein 1

Related Agents

  • Pre-clinical Phase

Pre-clinical Phase

Bioactive Molecules (2)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-RS08936 MYO19 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS29508 Myo19 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Myo19 NCBI NCBI:80179